🕵️ Phibro Animal Health Corp ($PAHC)
SEC insider & ownership activity, last 12 months · CIK 1069899 · every row links its SEC filing
Over the last 12 months insiders sold $32.0M against $318K of open-market buying. Bendheim Jack sold $32.0M through a 10b5-1 trading plan in 122 lots (Sep–May). Jack C. Bendheim trimmed 49.9% → 49.3%. No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $318K (1 lots) · 1 seller, $32.0M (122 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Bendheim Jack | 0 | – | 122 | $32.0M | May 7, 2026 |
| Corcoran E Thomas | 1 | $318K | 0 | – | May 29, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Jack C. Bendheim | 49.3% | 13D | Dec 11, 2025 | filing ↗ | |
| Jack C. Bendheim | 48.2% | 13D | May 20, 2026 | filing ↗ | |
| BFI Co., LLC | 48.2% | 13D | May 20, 2026 | filing ↗ | |
| Blackrock, Inc. | 15.7% | 13G | Apr 28, 2025 | filing ↗ | |
| FMR LLC | 10.5% | 13G | Apr 7, 2026 | filing ↗ | |
| Abigail P. Johnson | 10.5% | 13G | Apr 7, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| BFI Co. LLC | $9.0M | Jun 16, 2026 | filing ↗ |
| BFI Co. LLC | $12.2M | Mar 13, 2026 | filing ↗ |
| David Glenn | $647K | Feb 11, 2026 | filing ↗ |
| BFI Co. LLC | $12.9M | Dec 4, 2025 | filing ↗ |
| BFI Co. LLC | $11.0M | Sep 4, 2025 | filing ↗ |
| BFI Co., LLC | $8.2M | Aug 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 25, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 28, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 13, 2026 | filing ↗ |
| Earnings (2.02) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Other events (8.01) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 16, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Shareholder vote (5.07) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Other events (8.01) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 27, 2025 | filing ↗ |